TP53 and sarcoma: These syndromes are most commonly caused by having an inactivating mutation in genes with tumor-suppressing functions, such as TP53, which predisposes patients to multiple sarcoma types, NF1, which predisposes patients to neurofibrosarcoma, and RB1, which predisposes patients to osteosarcoma as well as soft tissue sarcomas [25].